Summary
The National Heart, Lung, and Blood Institute (NHLBI) is soliciting applications for clinical trial pilot studies under the R34 mechanism. This funding opportunity supports early-phase, small-scale clinical trial pilot or feasibility studies relevant to NHLBI's mission areas (heart, lung, blood, and sleep disorders). The R34 mechanism is designed to allow investigators to gather preliminary data and assess the feasibility of a larger clinical trial before committing full resources. Clinical trials are optional under this announcement, meaning non-trial research may also be submitted.